Gain Therapeutics Inc (GANX)

LOOOOL that’s a real ouchy bro.
$1.75!?!?!? 
Not buying till sub $1.00

Gain Therapeutics (GANX) Shares Edge Higher After Narrower-Than-Expected Q1 LossMay 11, 2026 9:51 AM
IH Market News Gain Therapeutics, Inc. (NASDAQ:GANX) shares rose 3.4% in premarket trading on Monday after the biotechnology company reported first-quarter results that came in ahead of analyst expectations.The clinical-stage biotech group posted an adjusted quarterly loss of $0.13 per share for the period ended March 31, 2026, slightly better than the consensus forecast of a $0.14 per share loss. Net Loss Widens as Development Spending Increases Gain Therapeutics reported a net loss of $5.6 million for the quarter, compared with a loss of $4.5 million during the same period last year.Research and development expenses increased to $2.8 million from $2.3 million year-over-year, driven primarily by continued investment in the development of GT-02287 and unfavorable foreign exchange movements.General and administrative costs also rose to $2.6 million, compared with $2.1 million in the prior-year quarter.“The first quarter of 2026 marked another exciting quarter for Gain, as we continued to build on the important advancements achieved in 2025 related to both the scientific understanding and clinical development of our lead candidate GT-02287, in development for the treatment of Parkinson’s disease with or without a GBA1 mutation,” said President and CEO Gene Mack. Company Highlights Progress in Parkinson’s Program Gain Therapeutics said it presented additional Phase 1b clinical data for GT-02287 during the AD/PD 2026 conference held in March.According to the company, the data demonstrated central target engagement and signs of clinical improvement among study participants.As of March 2026, 14 of the 16 participants enrolled in the nine-month extension study had completed five months of treatment, with MDS-UPDRS scores remaining stable across a 150-day period. Phase 2 Study Remains on Track for 2026 The company said it expects to receive FDA clearance for its Investigational New Drug (IND) application during the second quarter of 2026.Gain Therapeutics added that it remains on schedule to launch its Phase 2 clinical trial during the third quarter of 2026.Results from the ongoing Phase 1b study are expected to be released in the fourth quarter of 2026.Gain Therapeutics stock price Original: Gain Therapeutics (GANX) Shares Edge Higher After Narrower-Than-Expected Q1 Loss

Scam alertLots of heads gon get burned here

$GANX: Friday booommmmmmmmmm..... now $3

That was a bit of a surprise.

Was just $2.20 last night


GO $GANX

buy. its going up, trust me.

GANX................................................https://stockcharts.com/sc3/ui/?s=GANX&p=W&b=5&g=0&id=p86431144783

GANX............................................https://stockcharts.com/sc3/ui/?s=GANX&p=W&b=5&g=0&id=p86431144783

Trash ticker.Headed back to $1.50Might revisit then

GANX over $2

Not good 
Not good at all 

GANX under $2

$2 long ago
Not going any further

2 now good luck

Don't see it going back there any time soon maybe low 1.20s but even that is doubtful, trend has turned UP

I say likely $1.00 soon

I might buy back in around 60 cent retracement levels

we will likely see $2.55 next week. BAM

Parkinson update

https://www.globenewswire.com/news-release/2024/09/26/2953660/0/en/Gain-Therapeutics-To-Host-Virtual-Webinar-on-Results-From-Phase-1-Study-and-Design-of-Upcoming-Phase-1b-Trial-of-GT-02287-a-Novel-GCase-Targeting-Small-Molecule-Therapy-for-Parkins.html

Looks like about to take another LEG higher

seems like we are due for a news release soon.
fingers crossed!

Nice 50% move if u were paying attention

Hanging over 1, so you know someone is watching out

I bought some recently in the .90s, only Regret i didn't buy more now 1.50 prints yesterday

GANX new 52 week low

GANX new 52 week low

Market Blood Bath 2.95 LOD =]

2.95 today pickUP opportunity =] as Market Down Huge Blood Everywhere

GANX under $4

GANX 10Q due 3/26

Been on fire move 5.29 high
Ok to take a rest

Darn, looking good $GANX

GANX $4.60

GANX $4.50

1 thing is sure a cure is needed
Stock has fallen back under 4 again

1 thing is sure a cure is needed
Stock has fallen back under 4 again

$GANX $4 break

#GANX $3.77

$GANX $3.66,,

$GANX $3.50

$GANX $3.27

GANX $3.20

GANX $3.05

Going higher

GANX $2.97

Holy chit, I'm up over 9% in less than a week and it looks like it just might keep going in this direction with periods of consolidation. Thank you petey for the x post on the 14th. Took a look, bought some last week, very happy.

GANX $2.77

GANX $2.69

GANX $2.55

GANX —- $2.42

GANX $2.35

just hovering 4.90-5 range